 Zoladex versus orchiectomy treatment advanced prostate cancer randomized trial Zoladex Prostate Study Group preliminary results first patients multicenter study endocrine effects efficacy safety mg goserelin acetate Zoladex patients Stage prostate cancer patients Zoladex median follow-up time patients hundred ten days Median serum levels testosterone levels ng/dL weeks groups weeks objective response criteria National Prostatic Cancer Project percent percent patients Zoladex orchiectomy groups significant differences treatment groups distributions time treatment failure time progression adverse events treatment groups hot flashes cancer-related pain unspecified pain urinary symptoms results Zoladex alternative treatment advanced prostate cancer